These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 33065179)

  • 41. Comparison of the clinical effects of intermittently scanned and real-time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study.
    Urakami T; Terada H; Yoshida K; Kuwabara R; Mine Y; Aoki M; Shoji Y; Suzuki J; Morioka I
    J Diabetes Investig; 2022 Oct; 13(10):1745-1752. PubMed ID: 35532954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes.
    Slattery D; Choudhary P
    Diabetes Technol Ther; 2017 May; 19(S2):S55-S61. PubMed ID: 28541131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-CGM-T1D).
    Brown RE; Chu L; Norman GJ; Abitbol A
    Diabet Med; 2022 Nov; 39(11):e14937. PubMed ID: 36065977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes.
    Carlson AL; Mullen DM; Bergenstal RM
    Diabetes Technol Ther; 2017 May; 19(S2):S4-S11. PubMed ID: 28541137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inpatient Continuous Glucose Monitoring and Glycemic Outcomes.
    Levitt DL; Silver KD; Spanakis EK
    J Diabetes Sci Technol; 2017 Sep; 11(5):1028-1035. PubMed ID: 28290224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
    Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT
    Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of intermittently scanned continuous glucose monitoring in adult type 1 diabetes patients with suboptimal glycaemic control: A multi-centre randomized controlled trial.
    Yan J; Zhou Y; Zheng X; Zheng M; Lu J; Luo S; Yang D; Deng H; Xu W; Bi Y; Bao W; Weng J
    Diabetes Metab Res Rev; 2023 May; 39(4):e3614. PubMed ID: 36670050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method.
    Bruttomesso D; Laviola L; Avogaro A; Bonora E; Del Prato S; Frontoni S; Orsi E; Rabbone I; Sesti G; Purrello F;
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):421-431. PubMed ID: 30952574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.
    Fonseca VA; Grunberger G; Anhalt H; Bailey TS; Blevins T; Garg SK; Handelsman Y; Hirsch IB; Orzeck EA; Roberts VL; Tamborlane W;
    Endocr Pract; 2016 Aug; 22(8):1008-21. PubMed ID: 27214060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes.
    Maiorino MI; Buzzetti R; Irace C; Laviola L; Napoli N; Pitocco D; Esposito K;
    Endocrine; 2023 Nov; 82(2):215-225. PubMed ID: 37676398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?
    Bomholt T; Kofod D; Nørgaard K; Rossing P; Feldt-Rasmussen B; Hornum M
    Nephron; 2023; 147(2):91-96. PubMed ID: 35830847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "Empowering Us": A community-led survey of real-world perspectives of adults with type 1 diabetes using insulin pumps and continuous glucose monitoring to manage their glucose levels.
    Read M; Henshaw KN; Zaharieva DP; Brown TC; Varga AE; Bray C; Cox M; Goody-Rohdin PJ; Hider K; Jelleyman P; Jenkins A; Jones C; Kerr P; Leach R; Martin K; Oreskovic N; O'Sullivan G; Rucioch J; Sims C; Smart C; Speight J; Stanistreet J; Tippett M; Tivalu I; Withers T; O'Neal DN
    Diabetes Res Clin Pract; 2023 Aug; 202():110830. PubMed ID: 37451626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
    Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
    Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring.
    Edelman SV; Argento NB; Pettus J; Hirsch IB
    Diabetes Care; 2018 Nov; 41(11):2265-2274. PubMed ID: 30348844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy.
    Nemlekar PM; Hannah KL; Green CR; Norman GJ
    Diabetes Ther; 2024 Mar; 15(3):639-648. PubMed ID: 38289464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.
    Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
    Lancet; 2021 Jun; 397(10291):2275-2283. PubMed ID: 34089660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ambulatory glucose profile analysis of the juvenile diabetes research foundation continuous glucose monitoring dataset-Applications to the pediatric diabetes population.
    Forlenza GP; Pyle LL; Maahs DM; Dunn TC
    Pediatr Diabetes; 2017 Nov; 18(7):622-628. PubMed ID: 27878929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the SPECTRUM training programme for real-time continuous glucose monitoring: A real-world multicentre prospective study in 120 adults with type 1 diabetes.
    Schlüter S; Freckmann G; Heinemann L; Wintergerst P; Lange K
    Diabet Med; 2021 Feb; 38(2):e14467. PubMed ID: 33230860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SELF BLOOD GLUCOSE MONITORING UNDERESTIMATES HYPERGLYCEMIA AND HYPOGLYCEMIA AS COMPARED TO CONTINUOUS GLUCOSE MONITORING IN TYPE 1 AND TYPE 2 DIABETES.
    Mangrola D; Cox C; Furman AS; Krishnan S; Karakas SE
    Endocr Pract; 2018 Jan; 24(1):47-52. PubMed ID: 29144814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.